Biotechnology
The Biotechnology industry has a total of 599 stocks, with a combined market cap of $1.14 trillion and total revenue of $110.21 billion.
Market Cap
1.14T
Revenue
110.21B
Profits
-40.94B
PE Ratio
n/a
Profit Margin
-37.15%
Dividend Yield
0.04%
599 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.97B | -0.60% | 1,305,507 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.10B | -1.72% | 776,480 | 14.34B |
| 3 | ARGX | argenx SE | 47.07B | -5.56% | 829,890 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.93B | 1.19% | 880,313 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 35.76B | -8.48% | 746,013 | 5.34B |
| 6 | INSM | Insmed Incorporated | 32.33B | 0.94% | 2,212,455 | 606.42M |
| 7 | BNTX | BioNTech SE | 27.30B | -0.95% | 418,515 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 26.17B | 0.47% | 2,573,613 | 2.38B |
| 9 | MRNA | Moderna, Inc. | 20.42B | 0.66% | 5,759,190 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.39B | -0.59% | 3,079,383 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 20.12B | -1.06% | 1,994,153 | - |
| 12 | INCY | Incyte Corporation | 19.92B | 0.11% | 2,092,228 | 5.14B |
| 13 | GMAB | Genmab A/S | 17.83B | -0.17% | 1,373,570 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.06B | 0.43% | 595,933 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.11B | 1.61% | 2,925,126 | 502.08M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.06B | -0.41% | 3,336,665 | 944.00M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.25B | 0.77% | 1,291,866 | - |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.75B | -0.54% | 1,783,861 | 3.22B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.63B | -3.99% | 1,882,697 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.50B | -1.05% | 2,714,012 | 2.32B |
| 21 | RNAM | Avidity Biosciences, Inc. | 11.30B | 0.03% | 16,835,785 | 18.76M |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.23B | 2.49% | 337,985 | 958.40M |
| 23 | IBRX | ImmunityBio, Inc. | 9.82B | 0.10% | 37,879,424 | 113.29M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.48B | -2.04% | 429,439 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.44B | -3.13% | 1,052,389 | 6.23M |
| 26 | TECH | Bio-Techne Corporation | 9.06B | 0.09% | 2,177,452 | 1.22B |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.88B | 2.87% | 2,420,515 | 1.09B |
| 28 | PCVX | Vaxcyte, Inc. | 8.64B | -4.82% | 2,158,448 | - |
| 29 | AXSM | Axsome Therapeutics, Inc. | 8.35B | -0.63% | 1,002,851 | 638.50M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.17B | -1.61% | 2,102,890 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 8.08B | 1.42% | 215,437 | 389.13M |
| 32 | NUVL | Nuvalent, Inc. | 8.07B | -0.57% | 458,819 | - |
| 33 | CYTK | Cytokinetics, Incorporated | 7.66B | -0.41% | 1,997,241 | 88.04M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 7.60B | 4.80% | 1,396,914 | 39.21M |
| 35 | BLTE | Belite Bio, Inc | 7.07B | 0.27% | 216,498 | - |
| 36 | ACLX | Arcellx, Inc. | 6.66B | 0.11% | 11,616,308 | 22.29M |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.54B | -1.09% | 983,101 | 189.76M |
| 38 | COGT | Cogent Biosciences, Inc. | 6.36B | -1.28% | 1,948,083 | - |
| 39 | CRSP | CRISPR Therapeutics AG | 5.93B | 11.85% | 3,663,310 | 3.51M |
| 40 | PTGX | Protagonist Therapeutics, Inc. | 5.64B | 1.48% | 706,163 | 46.02M |
| 41 | PTCT | PTC Therapeutics, Inc. | 5.64B | 0.50% | 1,428,597 | 1.73B |
| 42 | IMVT | Immunovant, Inc. | 5.58B | 0.66% | 1,128,291 | - |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.56B | -15.13% | 2,172,874 | 521.31M |
| 44 | CAI | Caris Life Sciences, Inc. | 5.43B | 5.08% | 2,642,722 | 812.03M |
| 45 | CELC | Celcuity Inc. | 5.14B | 3.48% | 514,123 | - |
| 46 | APGE | Apogee Therapeutics, Inc. | 4.66B | -2.54% | 509,126 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.57B | -4.53% | 954,217 | - |
| 48 | CGON | CG Oncology, Inc. | 4.53B | -1.54% | 736,754 | 2.17M |
| 49 | TGTX | TG Therapeutics, Inc. | 4.52B | 4.18% | 3,894,041 | 616.29M |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.50B | -0.07% | 5,543,361 | 634.21M |
| 51 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.48B | 0.81% | 824,744 | 7.70M |
| 52 | GPCR | Structure Therapeutics Inc. | 4.48B | -2.68% | 940,343 | - |
| 53 | TERN | Terns Pharmaceuticals, Inc. | 4.45B | -1.11% | 2,087,506 | - |
| 54 | ERAS | Erasca, Inc. | 4.20B | 0.82% | 2,047,477 | - |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 4.17B | -1.32% | 3,972,358 | 1.07B |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 3.94B | -2.09% | 900,662 | 22.50M |
| 57 | CNTA | Centessa Pharmaceuticals plc | 3.91B | -0.74% | 948,600 | 15.00M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 3.86B | 2.50% | 256,576 | 268.09M |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.81B | -0.45% | 2,293,483 | - |
| 60 | CORT | Corcept Therapeutics Incorporated | 3.81B | -1.21% | 1,576,920 | 761.41M |
| 61 | ALMS | Alumis Inc. | 3.74B | 2.01% | 1,058,525 | 22.12M |
| 62 | ADMA | ADMA Biologics, Inc. | 3.61B | -3.19% | 7,476,870 | 510.17M |
| 63 | LEGN | Legend Biotech Corporation | 3.56B | -2.23% | 1,726,935 | 909.05M |
| 64 | ARQT | Arcutis Biotherapeutics, Inc. | 3.54B | 5.78% | 3,378,301 | 376.07M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.47B | 0.76% | 709,139 | 7.50M |
| 66 | SYRE | Spyre Therapeutics, Inc. | 3.39B | -1.66% | 534,838 | - |
| 67 | DNLI | Denali Therapeutics Inc. | 3.34B | -3.90% | 1,655,546 | - |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.23B | 4.43% | 501,413 | 451.36M |
| 69 | EWTX | Edgewise Therapeutics, Inc. | 3.14B | -1.53% | 729,238 | - |
| 70 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.04B | 0.08% | 1,521,311 | 588.99M |
| 71 | VERA | Vera Therapeutics, Inc. | 3.01B | 1.61% | 1,953,569 | - |
| 72 | BEAM | Beam Therapeutics Inc. | 2.87B | -2.33% | 3,041,783 | 139.74M |
| 73 | VRDN | Viridian Therapeutics, Inc. | 2.81B | 1.90% | 1,780,256 | 70.85M |
| 74 | WVE | Wave Life Sciences Ltd. | 2.81B | 5.64% | 3,724,583 | 42.73M |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 2.80B | 0.73% | 788,760 | 218.71M |
| 76 | APLS | Apellis Pharmaceuticals, Inc. | 2.77B | 1.03% | 2,222,061 | 1.00B |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.74B | 1.30% | 809,810 | 490.73M |
| 78 | LQDA | Liquidia Corporation | 2.68B | 2.63% | 2,142,655 | 69.22M |
| 79 | DYN | Dyne Therapeutics, Inc. | 2.67B | 0.62% | 1,769,467 | - |
| 80 | IRON | Disc Medicine, Inc. | 2.56B | 1.52% | 907,003 | - |
| 81 | ADPT | Adaptive Biotechnologies Corporation | 2.53B | 1.54% | 1,449,241 | 276.98M |
| 82 | RCUS | Arcus Biosciences, Inc. | 2.45B | -3.60% | 1,241,073 | 247.00M |
| 83 | IMNM | Immunome, Inc. | 2.42B | -1.13% | 639,874 | 9.68M |
| 84 | TLX | Telix Pharmaceuticals Limited | 2.41B | 10.75% | 444,006 | 803.79M |
| 85 | MLYS | Mineralys Therapeutics, Inc. | 2.30B | -0.68% | 1,188,861 | - |
| 86 | DNTH | Dianthus Therapeutics, Inc. | 2.30B | 2.39% | 970,018 | 3.08M |
| 87 | RARE | Ultragenyx Pharmaceutical Inc. | 2.22B | 0.57% | 1,341,530 | 673.00M |
| 88 | ZLAB | Zai Lab Limited | 2.21B | 1.55% | 528,403 | 460.16M |
| 89 | AAPG | Ascentage Pharma Group International | 2.21B | -2.59% | 1,227 | 54.52M |
| 90 | MAZE | Maze Therapeutics, Inc. | 2.21B | -2.94% | 339,815 | 2.50M |
| 91 | GLPG | Galapagos NV | 2.20B | -1.56% | 178,180 | 1.31B |
| 92 | OCUL | Ocular Therapeutix, Inc. | 2.09B | 0.95% | 8,046,353 | 51.95M |
| 93 | MESO | Mesoblast Limited | 2.05B | 0.06% | 206,251 | 65.38M |
| 94 | CLDX | Celldex Therapeutics, Inc. | 2.04B | -0.58% | 1,673,196 | 1.55M |
| 95 | STOK | Stoke Therapeutics, Inc. | 2.03B | 0.14% | 633,217 | 205.63M |
| 96 | SLNO | Soleno Therapeutics, Inc. | 1.99B | -7.12% | 4,190,286 | 190.41M |
| 97 | RXRX | Recursion Pharmaceuticals, Inc. | 1.99B | - | 16,933,401 | 74.68M |
| 98 | NUVB | Nuvation Bio Inc. | 1.99B | 4.32% | 3,550,696 | 26.75M |
| 99 | OLMA | Olema Pharmaceuticals, Inc. | 1.92B | 1.20% | 796,148 | - |
| 100 | VCEL | Vericel Corporation | 1.91B | 1.59% | 608,609 | 276.26M |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 1.85B | -3.19% | 1,366,311 | 283.06M |
| 102 | NKTR | Nektar Therapeutics | 1.84B | -6.35% | 1,442,398 | 62.60M |
| 103 | SRPT | Sarepta Therapeutics, Inc. | 1.83B | -8.01% | 6,179,918 | 2.20B |
| 104 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | -0.39% | 1,358,587 | 172.35M |
| 105 | PHVS | Pharvaris N.V. | 1.82B | 1.34% | 73,950 | - |
| 106 | NVAX | Novavax, Inc. | 1.82B | 17.42% | 23,916,397 | 1.12B |
| 107 | GLTO | Galecto, Inc. | 1.79B | -7.80% | 159,957 | - |
| 108 | RAPT | RAPT Therapeutics, Inc. | 1.79B | - | 1,019,777 | - |
| 109 | ZYME | Zymeworks Inc. | 1.78B | -1.29% | 687,655 | 134.48M |
| 110 | TYRA | Tyra Biosciences, Inc. | 1.77B | -3.83% | 756,928 | - |
| 111 | INVA | Innoviva, Inc. | 1.76B | -2.89% | 1,364,710 | 411.33M |
| 112 | ELVN | Enliven Therapeutics, Inc. | 1.76B | 1.16% | 731,210 | - |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 1.76B | 0.07% | 645,429 | 54.03M |
| 114 | PVLA | Palvella Therapeutics, Inc. | 1.76B | 15.35% | 1,231,538 | - |
| 115 | KOD | Kodiak Sciences Inc. | 1.73B | 1.30% | 576,062 | - |
| 116 | OCS | Oculis Holding AG | 1.73B | 1.45% | 360,814 | 992.00K |
| 117 | DFTX | Definium Therapeutics, Inc. | 1.70B | -1.87% | 1,123,739 | - |
| 118 | SION | Sionna Therapeutics, Inc. | 1.70B | -0.08% | 139,809 | - |
| 119 | HRMY | Harmony Biosciences Holdings, Inc. | 1.68B | 3.05% | 1,374,462 | 868.45M |
| 120 | ORKA | Oruka Therapeutics, Inc. | 1.66B | -2.72% | 192,377 | - |
| 121 | NRIX | Nurix Therapeutics, Inc. | 1.66B | 2.03% | 773,130 | 83.98M |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.65B | 6.41% | 4,894,172 | 67.67M |
| 123 | MBX | MBX Biosciences, Inc. | 1.65B | -1.68% | 396,371 | - |
| 124 | RLAY | Relay Therapeutics, Inc. | 1.64B | -0.65% | 1,735,639 | 15.36M |
| 125 | ARDX | Ardelyx, Inc. | 1.63B | 1.07% | 3,159,136 | 407.32M |
| 126 | IMCR | Immunocore Holdings plc | 1.62B | -0.37% | 653,213 | 400.02M |
| 127 | MANE | Veradermics, Incorporated | 1.60B | 1.75% | 159,351 | - |
| 128 | IOVA | Iovance Biotherapeutics, Inc. | 1.56B | -1.04% | 22,466,068 | 263.50M |
| 129 | ANAB | AnaptysBio, Inc. | 1.55B | 1.81% | 281,367 | 169.47M |
| 130 | TNGX | Tango Therapeutics, Inc. | 1.54B | -9.74% | 7,498,240 | 66.50M |
| 131 | CRVS | Corvus Pharmaceuticals, Inc. | 1.53B | 0.33% | 1,049,409 | - |
| 132 | BHVN | Biohaven Ltd. | 1.48B | -3.13% | 1,477,081 | - |
| 133 | EYPT | EyePoint, Inc. | 1.48B | 0.56% | 983,167 | 42.34M |
| 134 | TRVI | Trevi Therapeutics, Inc. | 1.48B | 1.41% | 1,024,460 | - |
| 135 | SVRA | Savara Inc. | 1.48B | 2.23% | 973,202 | - |
| 136 | GLUE | Monte Rosa Therapeutics, Inc. | 1.47B | 2.27% | 775,089 | 181.54M |
| 137 | VIR | Vir Biotechnology, Inc. | 1.46B | -6.80% | 21,339,110 | 68.56M |
| 138 | CAPR | Capricor Therapeutics, Inc. | 1.44B | -1.62% | 670,411 | 11.13M |
| 139 | ZBIO | Zenas BioPharma, Inc. | 1.41B | 1.27% | 445,355 | 15.00M |
| 140 | RAPP | Rapport Therapeutics, Inc. | 1.41B | -2.32% | 163,608 | - |
| 141 | IMTX | Immatics N.V. | 1.36B | -1.55% | 396,216 | 99.45M |
| 142 | SEPN | Septerna, Inc. | 1.36B | 0.97% | 253,558 | 22.05M |
| 143 | ORIC | ORIC Pharmaceuticals, Inc. | 1.35B | 0.75% | 1,043,095 | - |
| 144 | ATAI | AtaiBeckley Inc. | 1.35B | -14.06% | 9,565,078 | 3.02M |
| 145 | PGEN | Precigen, Inc. | 1.35B | -0.78% | 7,887,447 | 6.31M |
| 146 | NBTX | Nanobiotix S.A. | 1.31B | 6.28% | 34,827 | 11.93M |
| 147 | DBVT | DBV Technologies S.A. | 1.30B | -3.19% | 120,292 | 5.50M |
| 148 | MLTX | MoonLake Immunotherapeutics | 1.27B | -2.96% | 906,190 | - |
| 149 | TSHA | Taysha Gene Therapies, Inc. | 1.25B | -2.14% | 1,963,258 | 6.31M |
| 150 | IVA | Inventiva S.A. | 1.25B | -3.96% | 356,967 | 19.93M |
| 151 | SANA | Sana Biotechnology, Inc. | 1.14B | 2.40% | 1,983,712 | - |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.12B | -3.79% | 113,282 | 1.40M |
| 153 | XERS | Xeris Biopharma Holdings, Inc. | 1.12B | 1.20% | 1,732,020 | 266.14M |
| 154 | PHAR | Pharming Group N.V. | 1.12B | -2.56% | 23,496 | 362.27M |
| 155 | DAWN | Day One Biopharmaceuticals, Inc. | 1.10B | -2.56% | 2,547,784 | 158.18M |
| 156 | ABCL | AbCellera Biologics Inc. | 1.09B | 12.54% | 6,569,424 | 75.13M |
| 157 | QURE | uniQure N.V. | 1.07B | -31.18% | 17,678,858 | 15.75M |
| 158 | PHAT | Phathom Pharmaceuticals, Inc. | 1.06B | 10.06% | 1,799,269 | 175.11M |
| 159 | GERN | Geron Corporation | 1.05B | -4.07% | 20,965,871 | 183.88M |
| 160 | BCAX | Bicara Therapeutics Inc. | 1.04B | -4.05% | 641,192 | - |
| 161 | AKTS | Aktis Oncology, Inc. | 1.03B | 0.67% | 136,861 | 5.56M |
| 162 | CMPX | Compass Therapeutics, Inc. | 1.03B | -1.87% | 3,221,864 | 850.00K |
| 163 | VTYX | Ventyx Biosciences, Inc. | 1.00B | - | 702,694 | - |
| 164 | FTRE | Fortrea Holdings Inc. | 997.92M | 4.45% | 2,868,865 | 2.72B |
| 165 | MNKD | MannKind Corporation | 994.91M | -7.43% | 33,338,568 | 348.97M |
| 166 | URGN | UroGen Pharma Ltd. | 991.41M | 2.47% | 520,240 | 96.52M |
| 167 | XNCR | Xencor, Inc. | 973.87M | 13.11% | 1,511,209 | 125.58M |
| 168 | GHRS | GH Research PLC | 969.52M | -0.76% | 144,100 | - |
| 169 | VALN | Valneva SE | 961.20M | -4.12% | 22,754 | 211.09M |
| 170 | AVBP | ArriVent BioPharma, Inc. | 958.97M | -0.26% | 303,193 | - |
| 171 | SGP | SpyGlass Pharma, Inc. | 944.55M | -2.68% | 41,051 | - |
| 172 | CTMX | CytomX Therapeutics, Inc. | 928.51M | -5.19% | 2,206,478 | 113.63M |
| 173 | SPRY | ARS Pharmaceuticals, Inc. | 923.25M | 1.08% | 942,325 | 142.77M |
| 174 | TBPH | Theravance Biopharma, Inc. | 921.73M | -4.56% | 606,832 | 80.33M |
| 175 | MRVI | Maravai LifeSciences Holdings, Inc. | 910.32M | 9.20% | 3,844,658 | 185.74M |
| 176 | ABUS | Arbutus Biopharma Corporation | 903.92M | 2.17% | 885,219 | 14.61M |
| 177 | CGEM | Cullinan Therapeutics, Inc. | 898.55M | 5.92% | 820,127 | - |
| 178 | ARVN | Arvinas, Inc. | 849.63M | 0.60% | 708,422 | 262.60M |
| 179 | DRUG | Bright Minds Biosciences Inc. | 845.59M | -5.00% | 97,583 | - |
| 180 | EVMN | Evommune, Inc. | 839.49M | -10.82% | 486,031 | 13.00M |
| 181 | JANX | Janux Therapeutics, Inc. | 839.48M | 0.73% | 724,358 | 10.00M |
| 182 | SLS | SELLAS Life Sciences Group, Inc. | 837.79M | 8.13% | 7,323,397 | - |
| 183 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 819.88M | -0.49% | 440,142 | - |
| 184 | OMER | Omeros Corporation | 818.90M | 1.49% | 537,869 | - |
| 185 | ANNX | Annexon, Inc. | 801.92M | 5.70% | 4,159,364 | - |
| 186 | KALV | KalVista Pharmaceuticals, Inc. | 796.61M | - | 449,766 | 1.43M |
| 187 | AGMB | AgomAb Therapeutics NV | 780.28M | -0.62% | 104,065 | - |
| 188 | PRME | Prime Medicine, Inc. | 775.43M | 6.05% | 7,486,551 | 5.98M |
| 189 | GYRE | Gyre Therapeutics, Inc. | 774.39M | -1.50% | 96,963 | 107.27M |
| 190 | MPLT | MapLight Therapeutics, Inc. | 760.23M | -1.19% | 100,871 | - |
| 191 | KURA | Kura Oncology, Inc. | 752.70M | 1.05% | 1,184,520 | 104.03M |
| 192 | EIKN | Eikon Therapeutics, Inc. | 736.35M | -8.39% | 464,441 | - |
| 193 | MDXG | MiMedx Group, Inc. | 731.58M | -6.44% | 2,599,477 | 418.63M |
| 194 | DRTS | Alpha Tau Medical Ltd. | 676.14M | -5.82% | 345,842 | - |
| 195 | ENGN | enGene Holdings Inc. | 675.88M | -0.10% | 96,811 | - |
| 196 | PROK | ProKidney Corp. | 670.86M | -1.33% | 403,925 | 744.00K |
| 197 | JBIO | Jade Biosciences, Inc. | 669.82M | 0.41% | 231,486 | - |
| 198 | VOR | Vor Biopharma Inc. | 660.17M | -1.00% | 568,440 | - |
| 199 | RIGL | Rigel Pharmaceuticals, Inc. | 648.18M | 3.15% | 367,947 | 282.08M |
| 200 | ZURA | Zura Bio Limited | 642.31M | -3.29% | 572,251 | - |
| 201 | LXRX | Lexicon Pharmaceuticals, Inc. | 640.63M | - | 1,916,219 | 70.86M |
| 202 | YDES | YD Bio Limited | 634.99M | 7.12% | 11,117 | 510.36K |
| 203 | REPL | Replimune Group, Inc. | 634.98M | -6.22% | 1,045,661 | - |
| 204 | MGTX | MeiraGTx Holdings plc | 616.56M | -2.30% | 235,486 | 27.42M |
| 205 | ALLO | Allogene Therapeutics, Inc. | 613.51M | 7.91% | 7,333,576 | 22.00K |
| 206 | OCGN | Ocugen, Inc. | 613.15M | 0.54% | 9,812,049 | 5.37M |
| 207 | LBRX | LB Pharmaceuticals Inc | 613.00M | -3.62% | 196,730 | - |
| 208 | DSGN | Design Therapeutics, Inc. | 608.37M | -2.64% | 131,553 | - |
| 209 | NMRA | Neumora Therapeutics, Inc. | 603.28M | 2.60% | 387,479 | - |
| 210 | ANRO | Alto Neuroscience, Inc. | 599.27M | 1.58% | 108,967 | - |
| 211 | FULC | Fulcrum Therapeutics, Inc. | 581.42M | -2.78% | 873,482 | 80.00M |
| 212 | CRMD | CorMedix Inc. | 579.10M | 0.55% | 1,004,356 | 214.30M |
| 213 | CTNM | Contineum Therapeutics, Inc. | 576.43M | - | 150,467 | - |
| 214 | ALT | Altimmune, Inc. | 558.53M | -2.19% | 1,902,855 | 20.00K |
| 215 | DNA | Ginkgo Bioworks Holdings, Inc. | 551.88M | 3.52% | 978,942 | 170.16M |
| 216 | FBRX | Forte Biosciences, Inc. | 521.75M | 2.88% | 282,254 | - |
| 217 | ZVRA | Zevra Therapeutics, Inc. | 511.74M | 1.79% | 446,293 | 84.39M |
| 218 | ADCT | ADC Therapeutics SA | 511.61M | -3.28% | 572,066 | 75.21M |
| 219 | VNDA | Vanda Pharmaceuticals Inc. | 508.33M | 3.86% | 2,326,816 | 216.11M |
| 220 | LXEO | Lexeo Therapeutics, Inc. | 503.61M | 0.15% | 428,761 | - |
| 221 | EPRX | Eupraxia Pharmaceuticals Inc. | 493.54M | 1.61% | 283,634 | - |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 492.74M | -2.62% | 983,375 | 120.00K |
| 223 | RCKT | Rocket Pharmaceuticals, Inc. | 490.25M | 4.62% | 2,931,192 | - |
| 224 | SLDB | Solid Biosciences Inc. | 490.06M | -0.32% | 756,312 | - |
| 225 | LYEL | Lyell Immunopharma, Inc. | 488.82M | -2.00% | 75,622 | 41.00K |
| 226 | VTVT | vTv Therapeutics Inc. | 487.92M | 2.08% | 33,126 | 17.00K |
| 227 | IVVD | Invivyd, Inc. | 479.38M | -0.58% | 1,235,470 | 50.04M |
| 228 | TENX | Tenax Therapeutics, Inc. | 476.70M | -5.09% | 67,709 | - |
| 229 | LCTX | Lineage Cell Therapeutics, Inc. | 474.96M | 3.16% | 1,572,239 | 10.82M |
| 230 | LRMR | Larimar Therapeutics, Inc. | 472.46M | -7.23% | 12,949,095 | - |
| 231 | AUTL | Autolus Therapeutics plc | 471.07M | 0.57% | 1,881,818 | 51.13M |
| 232 | ASMB | Assembly Biosciences, Inc. | 468.03M | 0.85% | 90,179 | 37.19M |
| 233 | PRTA | Prothena Corporation plc | 465.09M | -2.70% | 355,723 | 9.68M |
| 234 | KYTX | Kyverna Therapeutics, Inc. | 463.89M | 0.37% | 414,153 | - |
| 235 | TRDA | Entrada Therapeutics, Inc. | 458.67M | 6.76% | 245,331 | 25.42M |
| 236 | KROS | Keros Therapeutics, Inc. | 457.91M | -1.25% | 291,257 | 246.72M |
| 237 | TECX | Tectonic Therapeutic, Inc. | 447.88M | 3.55% | 297,641 | - |
| 238 | IMMX | Immix Biopharma, Inc. | 447.38M | -2.97% | 526,843 | - |
| 239 | RGNX | REGENXBIO Inc. | 442.95M | 2.58% | 917,175 | 161.32M |
| 240 | VSTM | Verastem, Inc. | 441.48M | -1.89% | 982,461 | 13.38M |
| 241 | DMAC | DiaMedica Therapeutics Inc. | 440.95M | -3.18% | 265,065 | - |
| 242 | PEPG | PepGen Inc. | 428.99M | -2.50% | 240,235 | - |
| 243 | UPB | Upstream Bio, Inc. | 426.90M | 2.07% | 1,497,002 | 2.80M |
| 244 | LENZ | LENZ Therapeutics, Inc. | 423.04M | 2.27% | 705,789 | 17.50M |
| 245 | ABSI | Absci Corporation | 422.54M | 2.55% | 1,530,168 | 2.82M |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 418.17M | -1.57% | 207,688 | 66.98M |
| 247 | NAGE | Niagen Bioscience, Inc. | 414.86M | -2.81% | 776,272 | 124.71M |
| 248 | AVXL | Anavex Life Sciences Corp. | 413.32M | 1.36% | 858,850 | - |
| 249 | IMMP | Immutep Limited | 413.29M | -1.79% | 294,957 | 5.28M |
| 250 | IPSC | Century Therapeutics, Inc. | 402.41M | 2.75% | 1,543,966 | 113.34M |
| 251 | PRTC | PureTech Health plc | 401.00M | -5.07% | 5,532 | 6.39M |
| 252 | ARMP | Armata Pharmaceuticals, Inc. | 394.29M | 1.88% | 32,794 | 5.05M |
| 253 | BCYC | Bicycle Therapeutics plc | 391.23M | -1.57% | 221,469 | 28.34M |
| 254 | GLSI | Greenwich LifeSciences, Inc. | 389.59M | 7.62% | 190,518 | - |
| 255 | HELP | Cybin Inc. | 388.28M | 0.91% | 473,618 | - |
| 256 | BNTC | Benitec Biopharma Inc. | 383.31M | 1.73% | 79,161 | - |
| 257 | PBYI | Puma Biotechnology, Inc. | 382.97M | -1.04% | 492,730 | 228.37M |
| 258 | AURA | Aura Biosciences, Inc. | 379.75M | -0.66% | 179,658 | - |
| 259 | NBP | NovaBridge Biosciences | 378.15M | - | 951,411 | - |
| 260 | CADL | Candel Therapeutics, Inc. | 377.22M | -0.58% | 1,486,086 | - |
| 261 | AVIR | Atea Pharmaceuticals, Inc. | 365.63M | 1.30% | 257,870 | - |
| 262 | MNPR | Monopar Therapeutics Inc. | 365.24M | -1.73% | 167,814 | - |
| 263 | CLYM | Climb Bio, Inc. | 352.35M | 4.09% | 933,921 | - |
| 264 | RZLT | Rezolute, Inc. | 341.74M | -7.06% | 1,675,221 | - |
| 265 | ACRS | Aclaris Therapeutics, Inc. | 339.12M | -5.44% | 1,576,573 | 7.83M |
| 266 | ANL | Adlai Nortye Ltd. | 339.11M | -5.36% | 286,523 | -1.35M |
| 267 | FHTX | Foghorn Therapeutics Inc. | 337.43M | -0.69% | 123,514 | 24.52M |
| 268 | RLMD | Relmada Therapeutics, Inc. | 337.33M | 1.10% | 372,894 | - |
| 269 | STRO | Sutro Biopharma, Inc. | 335.46M | 0.15% | 41,241 | 105.65M |
| 270 | CABA | Cabaletta Bio, Inc. | 335.00M | -0.29% | 2,558,851 | - |
| 271 | XOMA | XOMA Royalty Corporation | 331.37M | 0.07% | 67,177 | 47.11M |
| 272 | ALDX | Aldeyra Therapeutics, Inc. | 330.90M | 0.18% | 939,723 | - |
| 273 | AVTX | Avalo Therapeutics, Inc. | 326.57M | 4.63% | 777,208 | 192.00K |
| 274 | IMRX | Immuneering Corporation | 322.20M | -4.77% | 674,866 | - |
| 275 | TARA | Protara Therapeutics, Inc. | 309.20M | -3.19% | 1,472,192 | - |
| 276 | ALXO | ALX Oncology Holdings Inc. | 308.31M | -2.89% | 2,289,779 | - |
| 277 | NAUT | Nautilus Biotechnology, Inc. | 305.66M | -16.26% | 309,334 | - |
| 278 | NGNE | Neurogene Inc. | 304.84M | -2.04% | 322,810 | 925.00K |
| 279 | CLLS | Cellectis S.A. | 299.44M | -3.83% | 41,044 | 82.55M |
| 280 | FENC | Fennec Pharmaceuticals Inc. | 294.06M | -2.93% | 135,158 | 38.79M |
| 281 | ACIU | AC Immune SA | 292.87M | 7.25% | 279,549 | 5.48M |
| 282 | IKT | Inhibikase Therapeutics, Inc. | 285.88M | -2.34% | 2,468,661 | 1.00 |
| 283 | XFOR | X4 Pharmaceuticals, Inc. | 284.17M | -5.52% | 829,964 | 33.98M |
| 284 | ABEO | Abeona Therapeutics Inc. | 281.80M | -1.89% | 906,543 | 400.00K |
| 285 | ALEC | Alector, Inc. | 279.43M | 7.11% | 1,311,259 | 21.05M |
| 286 | PALI | Palisade Bio, Inc. | 275.66M | -2.63% | 2,494,509 | - |
| 287 | ENLV | Enlivex Therapeutics Ltd. | 272.99M | 4.55% | 153,487 | - |
| 288 | AARD | Aardvark Therapeutics, Inc. | 272.17M | 0.97% | 30,787 | - |
| 289 | NERV | Minerva Neurosciences, Inc. | 269.60M | - | 30,332 | - |
| 290 | CCCC | C4 Therapeutics, Inc. | 269.42M | 0.36% | 4,396,832 | 30.11M |
| 291 | OABI | OmniAb, Inc. | 259.12M | 0.56% | 138,256 | 21.09M |
| 292 | SLN | Silence Therapeutics plc | 256.01M | 1.31% | 99,971 | 25.83M |
| 293 | STTK | Shattuck Labs, Inc. | 255.65M | -0.25% | 188,511 | 1.00M |
| 294 | CHRS | Coherus Oncology, Inc. | 252.61M | 0.60% | 636,534 | 277.73M |
| 295 | ACHV | Achieve Life Sciences, Inc. | 251.80M | 2.38% | 258,449 | - |
| 296 | SLGL | Sol-Gel Technologies Ltd. | 248.35M | -1.08% | 31,426 | 18.97M |
| 297 | IRD | Opus Genetics, Inc. | 247.58M | 2.57% | 460,898 | 14.63M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 244.49M | -0.46% | 99,671 | 2.82M |
| 299 | PLX | Protalix BioTherapeutics, Inc. | 242.07M | -0.66% | 917,966 | 61.84M |
| 300 | CBIO | Crescent Biopharma, Inc. | 237.92M | -2.56% | 68,662 | - |
| 301 | CBUS | Cibus, Inc. | 237.80M | -5.63% | 364,862 | 3.79M |
| 302 | HUMA | Humacyte, Inc. | 237.39M | 6.03% | 6,066,096 | 1.57M |
| 303 | NVCT | Nuvectis Pharma, Inc. | 236.84M | 0.11% | 33,070 | - |
| 304 | PRLD | Prelude Therapeutics Incorporated | 236.48M | -12.77% | 259,326 | 10.50M |
| 305 | ARCT | Arcturus Therapeutics Holdings Inc. | 236.41M | 0.24% | 310,815 | 97.60M |
| 306 | VYGR | Voyager Therapeutics, Inc. | 235.19M | 3.42% | 590,532 | 31.32M |
| 307 | CAMP | Camp4 Therapeutics Corporation | 232.95M | 0.90% | 21,619 | 3.80M |
| 308 | MDWD | MediWound Ltd. | 224.39M | 0.34% | 72,295 | 20.93M |
| 309 | SRZN | Surrozen, Inc. | 220.71M | -4.74% | 61,064 | 3.60M |
| 310 | HRTX | Heron Therapeutics, Inc. | 220.04M | 11.11% | 8,343,473 | 154.90M |
| 311 | RNAC | Cartesian Therapeutics, Inc. | 217.13M | 5.83% | 230,040 | 1.09M |
| 312 | OVID | Ovid Therapeutics Inc. | 214.80M | 1.85% | 767,301 | 6.61M |
| 313 | EDIT | Editas Medicine, Inc. | 212.81M | 2.35% | 2,131,715 | 46.38M |
| 314 | CNTX | Context Therapeutics Inc. | 209.48M | -6.17% | 1,242,866 | - |
| 315 | ELTX | Elicio Therapeutics, Inc. | 205.16M | 6.92% | 177,574 | - |
| 316 | GALT | Galectin Therapeutics Inc. | 202.44M | -2.48% | 301,491 | - |
| 317 | CNTN | Canton Strategic Holdings, Inc. | 198.44M | -2.14% | 688,131 | - |
| 318 | KLRS | Kalaris Therapeutics, Inc. | 197.50M | -0.66% | 14,441 | - |
| 319 | SABS | SAB Biotherapeutics, Inc. | 196.62M | 5.09% | 231,886 | 114.70K |
| 320 | NTHI | NeOnc Technologies Holdings, Inc. | 196.50M | 0.20% | 7,579 | 59.99K |
| 321 | ELDN | Eledon Pharmaceuticals, Inc. | 192.03M | -2.02% | 656,448 | - |
| 322 | SGMT | Sagimet Biosciences Inc. | 190.90M | -4.24% | 316,278 | - |
| 323 | PMN | ProMIS Neurosciences, Inc. | 187.07M | 5.04% | 46,185 | - |
| 324 | TLSA | Tiziana Life Sciences Ltd | 186.33M | 4.29% | 65,099 | - |
| 325 | NKTX | Nkarta, Inc. | 186.10M | 1.16% | 647,925 | - |
| 326 | CRBU | Caribou Biosciences, Inc. | 186.00M | 2.05% | 1,217,197 | 9.30M |
| 327 | TNXP | Tonix Pharmaceuticals Holding Corp. | 184.62M | -2.76% | 451,400 | 10.30M |
| 328 | MOLN | Molecular Partners AG | 183.61M | -3.37% | 3,610 | 856.30K |
| 329 | VXRT | Vaxart, Inc. | 180.22M | 4.32% | 1,131,883 | 148.20M |
| 330 | FATE | Fate Therapeutics, Inc. | 179.95M | 5.41% | 2,361,603 | 6.65M |
| 331 | MENS | Jyong Biotech Ltd. | 176.87M | -4.96% | 232,284 | - |
| 332 | MIST | Milestone Pharmaceuticals Inc. | 174.72M | -0.58% | 1,176,945 | - |
| 333 | ABOS | Acumen Pharmaceuticals, Inc. | 172.03M | 2.16% | 201,285 | - |
| 334 | KPTI | Karyopharm Therapeutics Inc. | 171.52M | -7.33% | 576,151 | 146.07M |
| 335 | RANI | Rani Therapeutics Holdings, Inc. | 167.70M | 2.22% | 1,383,705 | 1.20M |
| 336 | PRQR | ProQR Therapeutics N.V. | 167.50M | 3.25% | 279,916 | 18.86M |
| 337 | CGEN | Compugen Ltd. | 167.43M | 1.70% | 97,768 | 6.90M |
| 338 | IPHA | Innate Pharma S.A. | 166.27M | - | 1,434 | 14.84M |
| 339 | SGMO | Sangamo Therapeutics, Inc. | 163.54M | -6.38% | 4,278,178 | 32.88M |
| 340 | ZNTL | Zentalis Pharmaceuticals, Inc. | 159.93M | - | 576,405 | 26.87M |
| 341 | WHWK | Whitehawk Therapeutics, Inc. | 153.17M | -1.52% | 62,575 | 14.38M |
| 342 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 152.86M | 6.18% | 444,076 | - |
| 343 | PLYX | Polaryx Therapeutics, Inc. | 151.03M | 15.16% | 518,338 | - |
| 344 | UNCY | Unicycive Therapeutics, Inc. | 147.00M | 1.94% | 405,872 | - |
| 345 | ADAG | Adagene Inc. | 146.34M | -1.74% | 140,065 | 103.20K |
| 346 | BDTX | Black Diamond Therapeutics, Inc. | 142.44M | -3.47% | 583,712 | 70.00M |
| 347 | CNTB | Connect Biopharma Holdings Limited | 141.99M | -1.93% | 49,810 | 762.00K |
| 348 | ORMP | Oramed Pharmaceuticals Inc. | 136.52M | -8.04% | 179,108 | 2.00M |
| 349 | CRDF | Cardiff Oncology, Inc. | 134.00M | 2.62% | 1,219,961 | 593.00K |
| 350 | ARTV | Artiva Biotherapeutics, Inc. | 133.77M | 8.35% | 195,000 | 251.00K |
| 351 | TNYA | Tenaya Therapeutics, Inc. | 131.87M | 1.18% | 2,395,360 | - |
| 352 | ACOG | Alpha Cognition Inc. | 130.45M | -5.36% | 57,553 | 7.43M |
| 353 | GNLX | Genelux Corporation | 127.98M | -2.69% | 126,819 | 8.00K |
| 354 | MGNX | MacroGenics, Inc. | 125.25M | 3.13% | 605,977 | 127.63M |
| 355 | SPRO | Spero Therapeutics, Inc. | 124.51M | -0.45% | 273,237 | 40.55M |
| 356 | IMUX | Immunic, Inc. | 123.64M | 4.10% | 1,556,095 | - |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 122.98M | -3.24% | 449,334 | 182.34K |
| 358 | SEER | Seer, Inc. | 117.00M | -0.48% | 676,601 | 16.38M |
| 359 | COYA | Coya Therapeutics, Inc. | 116.77M | -1.39% | 69,715 | 3.99M |
| 360 | ONCY | Oncolytics Biotech Inc. | 115.14M | -3.60% | 1,594,639 | - |
| 361 | KRRO | Korro Bio, Inc. | 114.61M | 0.25% | 75,875 | 7.37M |
| 362 | AGEN | Agenus Inc. | 114.27M | 4.02% | 204,298 | 106.83M |
| 363 | SAVA | Cassava Sciences, Inc. | 113.52M | 3.98% | 553,480 | - |
| 364 | TTRX | Turn Therapeutics Inc. | 113.07M | 10.34% | 67,708 | - |
| 365 | FBIO | Fortress Biotech, Inc. | 109.25M | -0.85% | 433,896 | 62.30M |
| 366 | IBIO | iBio, Inc. | 106.05M | 6.97% | 1,579,839 | 300.00K |
| 367 | EQ | Equillium, Inc. | 105.65M | -5.19% | 465,386 | 4.39M |
| 368 | BMEA | Biomea Fusion, Inc. | 102.52M | 2.84% | 873,119 | - |
| 369 | CGTX | Cognition Therapeutics, Inc. | 102.40M | 3.57% | 509,597 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 101.47M | 0.66% | 48,555 | - |
| 371 | VANI | Vivani Medical, Inc. | 99.82M | -1.57% | 109,817 | - |
| 372 | HURA | TuHURA Biosciences, Inc. | 98.37M | -3.57% | 1,610,676 | - |
| 373 | ATYR | aTyr Pharma, Inc. | 97.01M | -2.94% | 1,408,507 | 190.00K |
| 374 | CDXS | Codexis, Inc. | 96.65M | -4.46% | 1,194,100 | 52.93M |
| 375 | KZIA | Kazia Therapeutics Limited | 96.43M | 16.45% | 405,902 | 1.20M |
| 376 | DTIL | Precision BioSciences, Inc. | 96.05M | -2.68% | 185,686 | 698.00K |
| 377 | GANX | Gain Therapeutics, Inc. | 95.39M | -1.59% | 465,600 | - |
| 378 | PYXS | Pyxis Oncology, Inc. | 94.64M | - | 172,692 | 2.82M |
| 379 | GOSS | Gossamer Bio, Inc. | 93.05M | 5.76% | 34,536,330 | 44.05M |
| 380 | DWTX | Dogwood Therapeutics, Inc. | 91.90M | -3.83% | 26,186 | - |
| 381 | ACTU | Actuate Therapeutics, Inc. | 91.81M | -2.71% | 48,998 | - |
| 382 | OKYO | OKYO Pharma Limited | 88.36M | 1.18% | 72,639 | - |
| 383 | VRCA | Verrica Pharmaceuticals Inc. | 87.46M | -1.80% | 92,904 | 30.83M |
| 384 | MAIA | MAIA Biotechnology, Inc. | 83.42M | -6.03% | 539,423 | - |
| 385 | CSBR | Champions Oncology, Inc. | 83.18M | 0.17% | 2,202 | 58.42M |
| 386 | MCRB | Seres Therapeutics, Inc. | 80.33M | -0.11% | 31,051 | 351.00K |
| 387 | PLRX | Pliant Therapeutics, Inc. | 79.27M | 0.78% | 689,460 | - |
| 388 | PYPD | PolyPid Ltd. | 76.82M | -1.63% | 67,508 | - |
| 389 | PTHS | Pelthos Therapeutics Inc. | 75.71M | 1.74% | 25,278 | 7.41M |
| 390 | MNOV | MediciNova, Inc. | 74.82M | 2.70% | 23,064 | 409.66K |
| 391 | EXOZ | eXoZymes, Inc. | 74.76M | -1.11% | 2,405 | -700.00 |
| 392 | ACET | Adicet Bio, Inc. | 73.98M | -1.21% | 47,139 | - |
| 393 | ANVS | Annovis Bio, Inc. | 73.41M | -3.82% | 354,791 | - |
| 394 | PMVP | PMV Pharmaceuticals, Inc. | 72.90M | 22.32% | 3,468,397 | - |
| 395 | IMA | ImageneBio, Inc. | 72.85M | 1.79% | 9,150 | 800.00K |
| 396 | GUTS | Fractyl Health, Inc. | 72.81M | -6.19% | 3,912,232 | 3.00K |
| 397 | ETHZ | ETHZilla Corporation | 72.63M | -2.30% | 420,489 | 4.11M |
| 398 | XBIT | XBiotech Inc. | 71.04M | -1.27% | 28,977 | - |
| 399 | COEP | Coeptis Therapeutics Holdings, Inc. | 70.04M | -0.96% | 9,052 | 501.00K |
| 400 | ENTX | Entera Bio Ltd. | 69.24M | -4.43% | 26,364 | 124.00K |
| 401 | CING | Cingulate Inc. | 67.62M | -4.70% | 393,657 | - |
| 402 | QTTB | Q32 Bio Inc. | 66.50M | 0.63% | 135,560 | - |
| 403 | GRCE | Grace Therapeutics, Inc. | 63.75M | 1.23% | 117,231 | - |
| 404 | IFRX | InflaRx N.V. | 63.09M | -0.25% | 204,673 | 73.73K |
| 405 | TCRX | TScan Therapeutics, Inc. | 62.99M | - | 461,772 | 8.42M |
| 406 | SPRB | Spruce Biosciences, Inc. | 62.67M | -0.31% | 17,538 | 697.00K |
| 407 | ATHE | Alterity Therapeutics Limited | 61.77M | 1.17% | 34,009 | 4.96M |
| 408 | NRXP | NRx Pharmaceuticals, Inc. | 61.51M | 1.05% | 460,834 | 242.00K |
| 409 | MREO | Mereo BioPharma Group plc | 61.42M | -2.03% | 2,290,526 | 500.00K |
| 410 | TIL | Instil Bio, Inc. | 60.97M | 5.15% | 56,815 | - |
| 411 | NRXS | NeurAxis, Inc. | 60.61M | 7.77% | 399,216 | 3.36M |
| 412 | MGX | Metagenomi Therapeutics, Inc. | 60.07M | 3.23% | 82,902 | 30.91M |
| 413 | ICCC | ImmuCell Corporation | 59.25M | -0.30% | 3,328 | 27.77M |
| 414 | TVGN | Tevogen Bio Holdings Inc. | 58.32M | 0.07% | 1,116,649 | - |
| 415 | ACRV | Acrivon Therapeutics, Inc. | 58.06M | 9.52% | 1,574,591 | - |
| 416 | RADX | Radiopharm Theranostics Limited | 57.88M | -2.35% | 22,051 | 8.20M |
| 417 | PSTV | Plus Therapeutics, Inc. | 57.37M | 7.67% | 7,048,997 | 5.26M |
| 418 | HYFT | MindWalk Holdings Corp. | 55.56M | -4.80% | 221,918 | 19.02M |
| 419 | LPCN | Lipocine Inc. | 55.52M | 5.49% | 267,200 | 4.32M |
| 420 | BYSI | BeyondSpring Inc. | 53.46M | - | 10,142 | 1.88M |
| 421 | LONA | LeonaBio, Inc. | 52.47M | -3.27% | 29,873 | - |
| 422 | NTRB | Nutriband Inc. | 52.39M | -3.36% | 7,222 | 2.28M |
| 423 | INKT | MiNK Therapeutics, Inc. | 51.78M | -4.09% | 2,655 | - |
| 424 | ESLA | Estrella Immunopharma, Inc. | 51.07M | 2.97% | 27,020 | - |
| 425 | OSTX | OS Therapies Incorporated | 50.36M | 3.62% | 345,056 | - |
| 426 | KZR | Kezar Life Sciences, Inc. | 49.14M | -0.74% | 21,624 | - |
| 427 | ALGS | Aligos Therapeutics, Inc. | 46.15M | 8.07% | 25,398 | 2.65M |
| 428 | IBO | Impact BioMedical Inc. | 45.51M | 1.16% | 25,463 | 25.00K |
| 429 | NXTC | NextCure, Inc. | 45.50M | -0.46% | 27,084 | - |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 45.04M | 1.55% | 146,281 | - |
| 431 | APLM | Apollomics, Inc. | 43.75M | -2.93% | 2,108 | 6.93M |
| 432 | VERU | Veru Inc. | 42.69M | 2.70% | 55,807 | 16.89M |
| 433 | LITS | Lite Strategy, Inc. | 41.45M | -3.39% | 254,401 | - |
| 434 | CRVO | CervoMed Inc. | 40.71M | 0.23% | 117,421 | 6.16M |
| 435 | NBY | NovaBay Pharmaceuticals, Inc. | 39.97M | -1.29% | 397,224 | 10.30M |
| 436 | XLO | Xilio Therapeutics, Inc. | 39.51M | -1.07% | 143,753 | 31.80M |
| 437 | LSTA | Lisata Therapeutics, Inc. | 38.90M | 0.46% | 32,807 | 1.07M |
| 438 | ATOS | Atossa Therapeutics, Inc. | 38.49M | 4.68% | 90,815 | - |
| 439 | JSPR | Jasper Therapeutics, Inc. | 38.34M | -2.14% | 119,591 | - |
| 440 | PDSB | PDS Biotechnology Corporation | 38.27M | -1.37% | 200,789 | - |
| 441 | SNSE | Sensei Biotherapeutics, Inc. | 38.24M | -11.71% | 235,805 | - |
| 442 | TVRD | Tvardi Therapeutics, Inc. | 37.99M | 5.19% | 49,076 | - |
| 443 | ATRA | Atara Biotherapeutics, Inc. | 37.93M | 3.95% | 510,863 | 151.93M |
| 444 | CVM | CEL-SCI Corporation | 36.90M | 3.87% | 34,752 | - |
| 445 | PLUR | Pluri Inc. | 36.89M | - | 1,409 | 1.34M |
| 446 | OKUR | OnKure Therapeutics, Inc. | 36.04M | -1.85% | 48,041 | - |
| 447 | OTLK | Outlook Therapeutics, Inc. | 35.99M | -1.46% | 427,787 | 205.70K |
| 448 | RLYB | Rallybio Corporation | 35.91M | 16.84% | 146,866 | 674.00K |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 35.88M | 0.88% | 60,772 | 90.00K |
| 450 | CELU | Celularity Inc. | 35.76M | -0.80% | 16,520 | 40.58M |
| 451 | INMB | INmune Bio Inc. | 35.62M | -3.60% | 424,125 | 50.00K |
| 452 | KLTO | Klotho Neurosciences, Inc. | 35.15M | 12.18% | 7,702,610 | - |
| 453 | PTN | Palatin Technologies, Inc. | 34.56M | 0.14% | 10,322 | 8.96M |
| 454 | ABVC | ABVC BioPharma, Inc. | 31.85M | -5.15% | 39,156 | 797.92K |
| 455 | LTRN | Lantern Pharma Inc. | 31.76M | -1.05% | 133,645 | - |
| 456 | RNXT | RenovoRx, Inc. | 31.70M | -4.95% | 187,980 | 928.00K |
| 457 | RNTX | Rein Therapeutics Inc. | 31.54M | -2.44% | 234,750 | - |
| 458 | TPST | Tempest Therapeutics, Inc. | 30.87M | -1.72% | 52,130 | - |
| 459 | HOWL | Werewolf Therapeutics, Inc. | 30.67M | -1.27% | 344,599 | 1.14M |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 30.12M | 2.49% | 86,536 | - |
| 461 | ANTX | AN2 Therapeutics, Inc. | 29.05M | - | 28,417 | - |
| 462 | BCTX | BriaCell Therapeutics Corp. | 28.83M | 2.56% | 156,330 | - |
| 463 | DYAI | Dyadic International, Inc. | 28.59M | -5.90% | 41,670 | 3.34M |
| 464 | KYNB | Kyntra Bio, Inc. | 28.20M | -4.13% | 69,548 | 8.30M |
| 465 | AEON | AEON Biopharma, Inc. | 27.58M | -5.22% | 67,763 | - |
| 466 | PASG | Passage Bio, Inc. | 27.53M | -7.08% | 55,213 | - |
| 467 | IGC | IGC Pharma, Inc. | 27.29M | -1.83% | 419,721 | 1.11M |
| 468 | EVAX | Evaxion A/S | 27.11M | -3.56% | 53,203 | 7.65M |
| 469 | MRKR | Marker Therapeutics, Inc. | 26.34M | 1.94% | 201,447 | 4.69M |
| 470 | CUE | Cue Biopharma, Inc. | 26.27M | 1.66% | 536,864 | 7.10M |
| 471 | HYPD | Hyperion DeFi, Inc. | 26.20M | -3.11% | 294,950 | 345.32K |
| 472 | BOLD | Boundless Bio, Inc. | 25.97M | -0.85% | 28,346 | - |
| 473 | IOBT | IO Biotech, Inc. | 25.83M | 5.16% | 412,026 | - |
| 474 | SNTI | Senti Biosciences, Inc. | 25.79M | 3.81% | 223,126 | - |
| 475 | LIXT | Lixte Biotechnology Holdings, Inc. | 25.35M | -4.28% | 35,347 | - |
| 476 | SKYE | Skye Bioscience, Inc. | 24.72M | 3.49% | 105,240 | - |
| 477 | BRNS | Barinthus Biotherapeutics plc | 24.50M | -1.64% | 24,494 | 14.97M |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 23.97M | 4.09% | 1,048,733 | 789.00K |
| 479 | DARE | Daré Bioscience, Inc. | 23.86M | -2.91% | 47,135 | -57.13K |
| 480 | XCUR | Exicure, Inc. | 23.65M | -2.11% | 15,793 | 500.00K |
| 481 | NEUP | Neuphoria Therapeutics Inc. | 23.50M | - | 13,946 | 14.99M |
| 482 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 23.37M | -9.30% | 11,966,889 | - |
| 483 | GNTA | Genenta Science S.p.A. | 22.50M | -3.99% | 54,013 | - |
| 484 | PLRZ | Polyrizon Ltd. | 21.82M | 1.11% | 64,147 | - |
| 485 | NNVC | NanoViricides, Inc. | 21.60M | -2.91% | 110,728 | - |
| 486 | INTS | Intensity Therapeutics, Inc. | 19.76M | 9.55% | 122,282 | - |
| 487 | VYNE | VYNE Therapeutics Inc. | 19.76M | 1.31% | 152,072 | 524.00K |
| 488 | CVKD | Cadrenal Therapeutics, Inc. | 19.59M | -2.90% | 64,587 | - |
| 489 | JUNS | Jupiter Neurosciences, Inc. | 19.53M | -5.87% | 49,801 | - |
| 490 | SER | Serina Therapeutics, Inc. | 19.52M | 2.26% | 54,858 | 116.00K |
| 491 | KTTA | Pasithea Therapeutics Corp. | 19.34M | -1.63% | 74,478 | - |
| 492 | FBLG | FibroBiologics, Inc. | 18.82M | 7.44% | 962,590 | - |
| 493 | LEXX | Lexaria Bioscience Corp. | 17.88M | 3.23% | 78,848 | 522.00K |
| 494 | BCAB | BioAtla, Inc. | 17.63M | 24.16% | 2,015,461 | 11.00M |
| 495 | ANEB | Anebulo Pharmaceuticals, Inc. | 17.58M | 0.65% | 21,384 | - |
| 496 | CTXR | Citius Pharmaceuticals, Inc. | 16.88M | 0.82% | 211,189 | 3.94M |
| 497 | INAB | IN8bio, Inc. | 16.70M | 3.01% | 23,384 | - |
| 498 | HOTH | Hoth Therapeutics, Inc. | 16.13M | -1.89% | 341,571 | - |
| 499 | ALLR | Allarity Therapeutics, Inc. | 16.00M | -0.49% | 62,765 | - |
| 500 | CRIS | Curis, Inc. | 15.20M | 2.78% | 82,640 | 11.65M |
| 501 | CLRB | Cellectar Biosciences, Inc. | 14.88M | 0.86% | 13,795 | - |
| 502 | COCP | Cocrystal Pharma, Inc. | 14.75M | 3.38% | 91,041 | - |
| 503 | QNTM | Quantum BioPharma Ltd. | 13.76M | -5.54% | 30,050 | - |
| 504 | BCDA | BioCardia, Inc. | 13.16M | - | 38,392 | 3.00K |
| 505 | NCEL | NewcelX Ltd. | 13.08M | -0.35% | 4,890 | - |
| 506 | TRAW | Traws Pharma, Inc. | 12.95M | 2.53% | 61,362 | 2.85M |
| 507 | EDSA | Edesa Biotech, Inc. | 12.94M | 13.97% | 8,053,893 | - |
| 508 | BLRX | BioLineRx Ltd. | 12.52M | 4.35% | 14,989 | 12.74M |
| 509 | GTBP | GT Biopharma, Inc. | 12.50M | 4.06% | 1,062,637 | - |
| 510 | ITRM | Iterum Therapeutics plc | 12.47M | -0.42% | 300,641 | 390.00K |
| 511 | GDTC | CytoMed Therapeutics Limited | 12.46M | - | 30,147 | 573.19K |
| 512 | LGVN | Longeveron Inc. | 12.37M | 5.72% | 1,095,229 | 1.44M |
| 513 | AKTX | Akari Therapeutics, Plc | 11.73M | -0.65% | 272,239 | - |
| 514 | SNGX | Soligenix, Inc. | 11.60M | -2.54% | 399,252 | 2.34K |
| 515 | PHIO | Phio Pharmaceuticals Corp. | 11.52M | 1.90% | 300,928 | - |
| 516 | KAPA | Kairos Pharma, Ltd. | 11.50M | -12.15% | 22,749,796 | - |
| 517 | MLEC | Moolec Science SA | 11.12M | -5.02% | 86,151 | 7.83M |
| 518 | OSRH | OSR Holdings, Inc. | 10.78M | -4.76% | 200,270 | -90.52K |
| 519 | IMNN | Imunon, Inc. | 10.75M | - | 21,759 | - |
| 520 | KALA | KALA BIO, Inc. | 10.73M | -5.94% | 403,323 | - |
| 521 | PULM | Pulmatrix, Inc. | 10.63M | -9.35% | 44,635 | 3.00K |
| 522 | ICU | SeaStar Medical Holding Corporation | 9.88M | 10.93% | 51,239 | 881.00K |
| 523 | LNAI | Lunai Bioworks Inc. | 9.67M | -5.97% | 177,811 | - |
| 524 | BIVI | BioVie Inc. | 9.58M | -1.55% | 55,428 | - |
| 525 | CMMB | Chemomab Therapeutics Ltd. | 9.54M | 7.64% | 236,086 | - |
| 526 | CDIO | Cardio Diagnostics Holdings, Inc. | 9.53M | -1.69% | 4,871,473 | 15.78K |
| 527 | RNAZ | TransCode Therapeutics, Inc. | 9.33M | 1.90% | 6,859 | - |
| 528 | NCNA | NuCana plc | 9.11M | -2.23% | 20,623 | - |
| 529 | BOLT | Bolt Biotherapeutics, Inc. | 8.89M | -5.51% | 51,569 | 5.20M |
| 530 | CLGN | CollPlant Biotechnologies Ltd. | 8.17M | -3.90% | 70,059 | 2.48M |
| 531 | GRDX | GridAI Technologies Corp. | 8.14M | -10.04% | 231,831 | - |
| 532 | LIMN | Liminatus Pharma, Inc. | 8.12M | -3.77% | 1,942,171 | - |
| 533 | ERNA | Ernexa Therapeutics Inc. | 8.07M | 1.71% | 836,301 | 1,000.00 |
| 534 | CALC | CalciMedica, Inc. | 7.95M | 1.85% | 144,105 | - |
| 535 | ALZN | Alzamend Neuro, Inc. | 7.91M | -1.89% | 48,969 | - |
| 536 | QNCX | Quince Therapeutics, Inc. | 7.71M | 4.92% | 31,000,607 | - |
| 537 | KPRX | Kiora Pharmaceuticals, Inc. | 7.70M | 2.94% | 27,240 | 20.00K |
| 538 | MBIO | Mustang Bio, Inc. | 7.52M | - | 18,520 | - |
| 539 | MBRX | Moleculin Biotech, Inc. | 7.42M | -6.59% | 169,352 | - |
| 540 | EVGN | Evogene Ltd. | 7.35M | -4.53% | 22,230 | 8.02M |
| 541 | APVO | Aptevo Therapeutics Inc. | 7.33M | 2.51% | 26,860 | - |
| 542 | ASBP | Aspire Biopharma Holdings, Inc. | 7.29M | 1.40% | 185,456 | 1.94K |
| 543 | PHGE | BiomX Inc. | 7.28M | -0.44% | 29,459 | - |
| 544 | ADXN | Addex Therapeutics Ltd | 7.23M | -10.95% | 591 | 198.82K |
| 545 | PMCB | PharmaCyte Biotech, Inc. | 7.13M | -2.36% | 66,667 | - |
| 546 | QNRX | Quoin Pharmaceuticals, Ltd. | 7.13M | -0.06% | 4,845 | - |
| 547 | TOVX | Theriva Biologics, Inc. | 7.02M | -1.40% | 2,265,763 | - |
| 548 | TCRT | Alaunos Therapeutics, Inc. | 7.01M | 0.32% | 9,833 | 6.00K |
| 549 | XTLB | XTL Biopharmaceuticals Ltd. | 6.65M | -4.61% | 24,928 | 968.00K |
| 550 | IMRN | Immuron Limited | 6.47M | -0.01% | 11,689 | 4.99M |
| 551 | CELZ | Creative Medical Technology Holdings, Inc. | 6.43M | -0.54% | 21,667 | 6.00K |
| 552 | APM | Aptorum Group Limited | 6.37M | -0.75% | 9,977 | - |
| 553 | REVB | Revelation Biosciences, Inc. | 6.31M | -5.67% | 127,981 | - |
| 554 | CLDI | Calidi Biotherapeutics, Inc. | 6.19M | 3.17% | 27,198 | - |
| 555 | APRE | Aprea Therapeutics, Inc. | 6.16M | 0.58% | 85,308 | 488.24K |
| 556 | PPBT | Purple Biotech Ltd | 5.94M | -4.43% | 126,346 | - |
| 557 | CANF | Can-Fite BioPharma Ltd. | 5.93M | 7.41% | 33,582 | 560.00K |
| 558 | VIVS | VivoSim Labs, Inc. | 5.82M | 8.78% | 184,141 | 142.00K |
| 559 | XBIO | Xenetic Biosciences, Inc. | 5.54M | -0.82% | 13,310 | 2.86M |
| 560 | SLXN | Silexion Therapeutics Corp | 5.44M | 5.45% | 26,012 | - |
| 561 | MTVA | MetaVia Inc. | 5.10M | -1.24% | 100,491 | - |
| 562 | SILO | Silo Pharma, Inc. | 5.06M | 2.93% | 1,053,914 | 72.10K |
| 563 | PCSA | Processa Pharmaceuticals, Inc. | 5.05M | 6.19% | 34,705 | - |
| 564 | CYCN | Cyclerion Therapeutics, Inc. | 4.99M | 0.77% | 28,368 | 2.86M |
| 565 | BRTX | BioRestorative Therapies, Inc. | 4.96M | 2.80% | 5,275,579 | 383.40K |
| 566 | BGMS | Bio Green Med Solution, Inc. | 4.95M | 3.29% | 20,187 | 81.00K |
| 567 | GNPX | Genprex, Inc. | 4.94M | 5.97% | 626,568 | - |
| 568 | INDP | Indaptus Therapeutics, Inc. | 4.63M | 4.72% | 8,035 | - |
| 569 | DCOY | Decoy Therapeutics Inc. | 4.36M | 0.15% | 68,476 | - |
| 570 | GLMD | Galmed Pharmaceuticals Ltd. | 4.28M | -1.75% | 26,784 | - |
| 571 | GOVX | GeoVax Labs, Inc. | 4.20M | -3.61% | 45,328 | 3.35M |
| 572 | ACXP | Acurx Pharmaceuticals, Inc. | 4.18M | 5.81% | 40,691 | - |
| 573 | ELAB | PMGC Holdings Inc. | 4.09M | 8.62% | 164,663 | 285.95K |
| 574 | JAGX | Jaguar Health, Inc. | 3.87M | -1.87% | 376,932 | 11.79M |
| 575 | MTNB | Matinas BioPharma Holdings, Inc. | 3.85M | -0.18% | 76,158 | - |
| 576 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.81M | -3.58% | 14,285 | 1.36M |
| 577 | OGEN | Oragenics, Inc. | 3.75M | 11.09% | 657,793 | - |
| 578 | GRI | GRI Bio, Inc. | 3.73M | 3.61% | 52,426 | - |
| 579 | ENVB | Enveric Biosciences, Inc. | 3.23M | -3.33% | 120,409 | - |
| 580 | HCWB | HCW Biologics Inc. | 3.16M | 4.49% | 901,109 | 422.03K |
| 581 | PPCB | Propanc Biopharma, Inc. | 3.10M | -3.13% | 260,801 | - |
| 582 | SCNI | Scinai Immunotherapeutics Ltd. | 3.02M | -4.40% | 7,166 | 1.15M |
| 583 | PBM | Psyence Biomedical Ltd. | 3.01M | 2.34% | 36,757 | - |
| 584 | DRMA | Dermata Therapeutics, Inc. | 2.98M | 2.46% | 112,074 | - |
| 585 | SPRC | SciSparc Ltd. | 2.98M | 5.21% | 138,392 | 1.31M |
| 586 | ADIL | Adial Pharmaceuticals, Inc. | 2.81M | 3.69% | 62,254 | - |
| 587 | ARTL | Artelo Biosciences, Inc. | 2.63M | 2.48% | 19,397 | - |
| 588 | XRTX | XORTX Therapeutics Inc. | 2.49M | 1.00% | 54,786 | - |
| 589 | BBLG | Bone Biologics Corporation | 2.06M | -0.86% | 11,163 | - |
| 590 | CMND | Clearmind Medicine Inc. | 2.06M | -1.71% | 42,560 | - |
| 591 | LYRA | Lyra Therapeutics, Inc. | 1.99M | -20.00% | 124,381 | 600.00K |
| 592 | AZTR | Azitra, Inc. | 1.95M | -0.55% | 998,314 | 7.50K |
| 593 | CDT | CDT Equity Inc. | 1.91M | -4.74% | 193,417 | - |
| 594 | CNSP | CNS Pharmaceuticals, Inc. | 1.90M | 2.68% | 5,387 | - |
| 595 | VRAX | Virax Biolabs Group Limited | 1.64M | -8.68% | 232,377 | 2.99K |
| 596 | ENSC | Ensysce Biosciences, Inc. | 1.43M | -0.38% | 1,515,064 | 4.49M |
| 597 | ONCO | Onconetix, Inc. | 1.03M | 0.08% | 80,402 | 1.22M |
| 598 | BDRX | Biodexa Pharmaceuticals Plc | 947.83K | - | 117,520 | 104.90K |
| 599 | ADTX | Aditxt, Inc. | 851.43K | -5.20% | 177,289 | 5.95K |